Clinical Trial Update: Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating early stoppage versus continuation of antimicrobial therapy in low-risk pediatric cancer patients with febrile neutropenia before cou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Cancer
• Febrile Neutropenia

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Neutropenia, Febrile, Pediatric Cancer | Phase 3 | Status: TERMINATED